Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
作者： Maki Komiyama , Rieko Takanabe , Koh Ono , Sayaka Shimada , Hiromichi Wada
关键词: Monocyte 、 Internal medicine 、 Blood vessel 、 Medicine 、 Blood pressure 、 Obesity 、 Inflammation 、 Immunology 、 Smoking cessation 、 Endocrinology 、 Cytokine 、 Body mass index
摘要: ObjectiveThe expression level of monocyte chemoattractant protein-1 (MCP-1) is increased in atherosclerotic regions, inducing migration to the blood vessel wall. Although serum MCP-1 concentration higher patients with than without cardiovascular disease, precise correlations between and factors associated smoking atherosclerosis are unknown.MethodsThe was measured using an enzyme-linked immunosorbent assay 207 consecutive smokers who visited our cessation clinic.ResultsSex-adjusted analysis revealed that positively correlated age (β = 0.311), duration (β = 0.342), systolic pressure (β = 0.225), diastolic (β = 0.137) but not body mass index. Multivariate regression showed were independent determinants concentration.ConclusionsThe ...
sagepub.com
sci-hub.se 参考文章(36)
Richard J McManus, F D Richard Hobbs, Jonathan Mant, Martyn R P Hull, Does changing from mercury to electronic blood pressure measurement influence recorded blood pressure? An observational study. British Journal of General Practice. ,vol. 53, pp. 953- 956 ,(2003)
Arsen Arakelyan, Roksana Zakharyan, Marina Hambardzumyan, Jana Petrkova, M. Charlotte Olsson, Martin Petrek, Anna Boyajyan, Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke. Journal of Interferon and Cytokine Research. ,vol. 34, pp. 100- 105 ,(2014) , 10.1089/JIR.2013.0030
Xiao-Yan Bai, Shujing Li, Miao Wang, Xinjian Qu, Gaolei Hu, Zhaowei Xu, Min Chen, Guo-Wei He, Huijian Wu, Association of Monocyte Chemoattractant Protein‐1 (MCP‐1)‐2518A>G Polymorphism with Susceptibility to Coronary Artery Disease: A Meta‐Analysis Annals of Human Genetics. ,vol. 79, pp. 173- 187 ,(2015) , 10.1111/AHG.12105
Miina Ohman, Daniel Eitzman, Targeting MCP-1 to reduce vascular complications of obesity. Recent Patents on Cardiovascular Drug Discovery. ,vol. 4, pp. 164- 176 ,(2009) , 10.2174/157489009789152230
Elena Dragomir, Maya Simionescu, None, Monocyte Chemoattractant Protein-1 – a major contributor to the inflammatory process associated with diabetes Archives of Physiology and Biochemistry. ,vol. 112, pp. 239- 244 ,(2006) , 10.1080/13813450601094672
Stefan Störk, Klaus Baumann, Clemens von Schacky, Peter Angerer, The effect of 17β-estradiol on MCP-1 serum levels in postmenopausal women Cardiovascular Research. ,vol. 53, pp. 642- 649 ,(2002) , 10.1016/S0008-6363(01)00461-8
WILLIAM W. K. ZUNG, Self-Rating Depression Scale in an Outpatient Clinic Archives of General Psychiatry. ,vol. 13, pp. 508- 515 ,(1965) , 10.1001/ARCHPSYC.1965.01730060026004
Jun Panee, Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine. ,vol. 60, pp. 1- 12 ,(2012) , 10.1016/J.CYTO.2012.06.018
Shiro Kitamoto, Kensuke Egashira, Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases. Expert Review of Cardiovascular Therapy. ,vol. 1, pp. 393- 400 ,(2003) , 10.1586/14779072.1.3.393
Henrike Sell, Jürgen Eckel, Monocyte chemotactic protein-1 and its role in insulin resistance. Current Opinion in Lipidology. ,vol. 18, pp. 258- 262 ,(2007) , 10.1097/MOL.0B013E3281338546